Key facts
- Aurie’s last known valuation is $15.9M (May 2023).
- It has raised $7.8M; the latest was Later Stage VC in Mar 2025.
- Notable investors include US National Science Foundation, MassChallenge, Impact Assets, MedTech Innovator, United States Department of War — 30 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Aurie
- ·The full record, as it builds
Funding rounds
No funding rounds for Aurie are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aurie
Developer of a reusable, no-touch catheter system designed to support safe and independent urinary care for people with mobility or neurological conditions. The company offers a portable, battery-operated case that washes, dries, and stores catheters, enabling individuals with chronic bladder conditions to perform catheterization.
- Sector
- Healthcare
- HQ
- Syracuse, NY, United States
- Founded
- 2018
- Employees
- 9
- Website
- livewithaurie.com/
- Ownership
- Privately Held (backing)
Aurie doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aurie shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aurie in its N-PORT filings yet. We sweep new filings monthly.